1. Home
  2. HERE vs OKYO Comparison

HERE vs OKYO Comparison

Compare HERE & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Here Group Limited American Depositary Shares

HERE

Here Group Limited American Depositary Shares

HOLD

Current Price

$1.90

Market Cap

100.1M

Sector

Real Estate

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.48

Market Cap

87.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HERE
OKYO
Founded
2019
2007
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.1M
87.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
HERE
OKYO
Price
$1.90
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
17.0K
59.0K
Earning Date
06-05-2026
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$79.29
N/A
P/E Ratio
$2.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$1.34
52 Week High
$5.80
$3.20

Technical Indicators

Market Signals
Indicator
HERE
OKYO
Relative Strength Index (RSI) 54.23 43.89
Support Level $1.81 $1.46
Resistance Level $1.95 $1.72
Average True Range (ATR) 0.05 0.10
MACD 0.01 -0.00
Stochastic Oscillator 89.03 29.09

Price Performance

Historical Comparison
HERE
OKYO

About HERE Here Group Limited American Depositary Shares

Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

Share on Social Networks: